Comparison of Two Liver Dialysis Systems : MARS Versus SPAD in Severe Liver Failure

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
A critical issue of the clinical syndrome in liver failure is the accumulation of toxins not cleared by the failing liver. Based on this hypothesis, albumin dialysis is used to remove those substances. Albumin dialysis with recirculation (MARS) is the most used system but required specific system and expert environment. Alternative system without recirculation (SPAD) is less expensive and can be realised in critical care services trained to extrarenal epuration. The primary objective of this study is to compare biological and clinical efficacy, pulsatility index of middle cerebral artery modification and tolerance of both systems. This is a prospective, open, cross-over comparative study of two albumin dialysis system. Each patient will receive the two systems in an randomly assessed order. Patients are divided up according to bilirubin plasmatic level. (250µmol/L to 400 µmol/L and \>400µmol/L).
Epistemonikos ID: 9b1e4710165c697bcab2163922f1c70dcd37f42f
First added on: May 12, 2024